Strengths

Strengths

[Published] 2025/3/4 [Last updated] 2025/3/25

NCC in Japan

  • National Cancer Center (NCC) is a leading cancer treatment and research center in Japan.
  • NCC has two hospitals and one Research Institute (RI).
  • NCCH (Tsukiji) and NCCE (Kashiwa) have 560 and 450 in-patient beds, respectively (total; 1000).
  • Each hospital has similar performance according to the in-patient capacity.
  • In NCC-RI, fundamental basic research is main expertise. And also, a lot of translational researches are ongoing in collaboration with academia, pharma in Japan as well as overseas.
NCC in Japan

Our Vision & Strengths

  • Early development of first/best-in-class drugs and novel therapies by participating in novel global FIH phase 1 trials.
  • Integrate nationwide genomics operation from foundational basic science to translational and prevision medicine at phase 1 clinic.
  • Tight link to NCCRI in order to collaborate with external stakeholders/partners involved in early phase drug development and translational research (academic centers, start-up and pharmaceutical companies).

NCC and the nationwide cancer care network

Turn-around time (from IRB submission to Contract) improved notably

Serial tumor biopsy in FIH

Serial tumor biopsy in FIH
  • Success rates of
  • Pre-treatment biopsy: 98.6%
  • On-treatment biopsy: 94.2%

Pre-treatment biopsy

On-treatment biopsy

On-treatment biopsy

On-treatment biopsy